Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wearable patch and phone app could spot dangerous fevers before they spike in cancer therapy

NCT ID NCT06415656

Completed Knowledge-focused Sponsor: Duke University Source: ClinicalTrials.gov ↗

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This study tests two devices — a wearable temperature patch and a smartphone app that measures vital signs from a facial scan — in adults with blood cancers receiving CAR-T or bispecific T-cell engager therapy. The goal is to see if these tools can detect fevers and other signs of cytokine release syndrome earlier than standard care. Earlier detection could lead to quicker treatment and fewer complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
TempTraq wearable temperature patch and VitalTraq smartphone app for remote vital sign monitoring
What this could lead to
If successful, this approach could enable earlier detection of cytokine release syndrome and other treatment side effects, potentially improving patient safety and outcomes.
What could go wrong
This is a small, early-stage feasibility study. The devices may not be accurate enough to replace standard monitoring, and results may not apply to all patients or treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOLOGIC MALIGNANCY

Contacts and locations

Locations

  • Duke Blood Cancer Center

    Durham, North Carolina, 27705, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.